- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
June 29th, 2010
Venture capitalists and their limited partners have long bemoaned lackluster returns and the lengthening time until exits for portfolio companies. Publicly held venture firm Harris & Harris Group has gotten tired of waiting, and said it plans to invest more in public companies in a bid to make faster returns.
Since 2002, Harris & Harris has focused on backing companies with products based on nanotechnology or microsystems. Its private-company portfolio includes Mersana Therapeutics Inc., which develops cancer therapies based on its biodegradable polymer technology, and Solazyme Inc., which uses algae to produce clean fuels, chemicals, foods and health-science products.
|Related News Press|
News and information
Doubling down on Schrödinger's cat May 27th, 2016
Deep Space Industries and SFL selected to provide satellites for HawkEye 360’s Pathfinder mission: The privately-funded space-based global wireless signal monitoring system will be developed by Deep Space Industries and UTIAS Space Flight Laboratory May 26th, 2016
Nanometrics Announces Upcoming Investor Events May 10th, 2016
Aspen Aerogels to Present at the 28th Annual ROTH Conference March 14th, 2016
Arrowhead to Webcast Fiscal 2015 Year End Results December 7th, 2015
Haydale Announce Year End Results November 3rd, 2015